174 related articles for article (PubMed ID: 18446536)
1. Breastfeeding in polycystic ovary syndrome.
Vanky E; Isaksen H; Moen MH; Carlsen SM
Acta Obstet Gynecol Scand; 2008; 87(5):531-5. PubMed ID: 18446536
[TBL] [Abstract][Full Text] [Related]
2. Mid-pregnancy androgen levels are negatively associated with breastfeeding.
Carlsen SM; Jacobsen G; Vanky E
Acta Obstet Gynecol Scand; 2010; 89(1):87-94. PubMed ID: 19900072
[TBL] [Abstract][Full Text] [Related]
3. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls.
Panidis D; Farmakiotis D; Koliakos G; Rousso D; Kourtis A; Katsikis I; Asteriadis C; Karayannis V; Diamanti-Kandarakis E
Hum Reprod; 2005 Aug; 20(8):2127-32. PubMed ID: 15890737
[TBL] [Abstract][Full Text] [Related]
5. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.
Vanky E; Salvesen KA; Heimstad R; Fougner KJ; Romundstad P; Carlsen SM
Hum Reprod; 2004 Aug; 19(8):1734-40. PubMed ID: 15178665
[TBL] [Abstract][Full Text] [Related]
6. Breast size increment during pregnancy and breastfeeding in mothers with polycystic ovary syndrome: a follow-up study of a randomised controlled trial on metformin versus placebo.
Vanky E; Nordskar JJ; Leithe H; Hjorth-Hansen AK; Martinussen M; Carlsen SM
BJOG; 2012 Oct; 119(11):1403-9. PubMed ID: 22827167
[TBL] [Abstract][Full Text] [Related]
7. Body fat composition and distribution in women with polycystic ovary syndrome.
Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
[TBL] [Abstract][Full Text] [Related]
8. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
[TBL] [Abstract][Full Text] [Related]
9. Duration of breastfeeding and breastfeeding problems in relation to length of postpartum stay: a longitudinal cohort study of a national Swedish sample.
Waldenström U; Aarts C
Acta Paediatr; 2004 May; 93(5):669-76. PubMed ID: 15174793
[TBL] [Abstract][Full Text] [Related]
10. PCOS--what matters in early pregnancy?--data from a cross-sectional, multicenter study.
Vanky E; Stridsklev S; Skogøy K; Kleggetveit O; Hjelle S; Brandis PV; Eikeland T; Flo K; Berg KF; Bunford G; Lund A; Bjerke C; Almås I; Berg AH; Danielsson A; Lahmami G; Carlsen SM
Acta Obstet Gynecol Scand; 2011 Apr; 90(4):398-404. PubMed ID: 21306318
[TBL] [Abstract][Full Text] [Related]
11. Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?
Sverrisdóttir YB; Mogren T; Kataoka J; Janson PO; Stener-Victorin E
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E576-81. PubMed ID: 18198350
[TBL] [Abstract][Full Text] [Related]
12. Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome.
Carlsen SM; Vanky E; Fleming R
Hum Reprod; 2009 Jul; 24(7):1732-8. PubMed ID: 19342396
[TBL] [Abstract][Full Text] [Related]
13. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
Ludwig AK; Goharian LG; Dietze T; Tauchert S; Rudolf S; Diedrich K; Schweiger U; Oltmanns KM
Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hand functions in women with polycystic ovary syndrome.
Soyupek F; Guney M; Eris S; Cerci S; Yildiz S; Mungan T
Gynecol Endocrinol; 2008 Oct; 24(10):571-5. PubMed ID: 19012100
[TBL] [Abstract][Full Text] [Related]
16. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone.
Mueller A; Dittrich R; Cupisti S; Beckmann MW; Binder H
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):182-7. PubMed ID: 16705550
[TBL] [Abstract][Full Text] [Related]
17. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters.
Mitkov M; Pehlivanov B; Orbetzova M
Gynecol Endocrinol; 2008 Nov; 24(11):625-30. PubMed ID: 19031219
[TBL] [Abstract][Full Text] [Related]
18. Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study.
Palomba S; Giallauria F; Falbo A; Russo T; Oppedisano R; Tolino A; Colao A; Vigorito C; Zullo F; Orio F
Hum Reprod; 2008 Mar; 23(3):642-50. PubMed ID: 18158291
[TBL] [Abstract][Full Text] [Related]
19. Assessment of diagnostic competence of plasmatic androgens on polycystic ovary syndrome based on receiver operator characteristic curves.
Villarroel C; Trejo L; Muñoz A; Kohen P; Fuentes A; Devoto L
Gynecol Endocrinol; 2010 Aug; 26(8):600-6. PubMed ID: 20222834
[TBL] [Abstract][Full Text] [Related]
20. The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome.
Ferk P; Teran N; Gersak K
Hum Reprod; 2007 Apr; 22(4):1031-6. PubMed ID: 17189294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
